Coverage
-
May 29, 2020
Gilead nabbed a partial victory in its patent battle with the University of Minnesota when the Patent Trial and Appeal Board agreed to take up one challenge to the university's patent covering a compound with anti-viral and anti-cancer properties, but not another.
1 other articles on this case.
View all »